3020-OL:HK:HK-X DBMSCIUSA (HKD)

COMMON STOCK | Other |

Last Closing

USD 1167

Change

+4.50 (+0.39)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-26 )

Largest Industry Peers for Other

Symbol Name Price(Change) Market Cap
1863:HK China Longevity Group Company ..

N/A

USD 1.17B
8355:HK I-CONTROL

-0.01 (-2.50%)

USD 0.39B
8343:HK HongGuang Lighting Holdings Co..

+0.05 (+11.11%)

USD 0.31B
0648:HK CHINA RENJ

N/A

USD 0.12B
0177-OL:HK JIANGSU EXPRESS

-0.03 (-0.38%)

N/A
0240-OL:HK BUILD KING HOLD

+0.01 (+0.93%)

N/A
0243-OL:HK QPL INT'L

+0.01 (+3.98%)

N/A
0182-OL:HK CHINA WINDPOWER

-0.01 (-1.59%)

N/A
0259-OL:HK YEEBO (INT'L H)

-0.04 (-1.12%)

N/A
0187-OL:HK JINGCHENG MAC

-0.04 (-1.63%)

N/A

ETFs Containing 3020-OL:HK

IHF iShares U.S. Healthcare P.. 9.70 % 0.43 %

-0.27 (-0.17%)

USD 0.82B
TETF 6.19 % 0.64 %

N/A

N/A
FHI-B:CA CI Health Care Giants Cov.. 5.11 % 0.00 %

N/A

CAD 0.05B
WBIL WBI BullBear Quality 3000.. 4.55 % 1.07 %

+0.06 (+-0.17%)

USD 0.04B
LCG Sterling Capital Focus Eq.. 4.26 % 0.00 %

-0.48 (-0.17%)

USD 0.07B
MID American Century Mid Cap .. 4.14 % 0.00 %

-0.69 (-0.17%)

USD 0.06B
IAI iShares U.S. Broker-Deale.. 3.82 % 0.42 %

+0.14 (+-0.17%)

USD 0.49B
STNC Stance Equity ESG Large C.. 3.75 % 0.00 %

+0.03 (+-0.17%)

USD 0.11B
CBUF:XETRA iShares MSCI World Health.. 3.57 % 0.00 %

N/A

USD 1.13B
HDIV 2.83 % 0.00 %

N/A

N/A
SPVU Invesco S&P 500® Enhance.. 2.73 % 0.16 %

+0.17 (+-0.17%)

USD 0.11B
UC96:LSE UBS (Irl) ETF plc - Facto.. 2.39 % 0.00 %

-1.00 (-0.17%)

USD 0.35B
UPVL:LSE UBS (Irl) ETF plc - Facto.. 2.39 % 0.00 %

-6.50 (-0.17%)

USD 8.21M
UBUS:F UBS (Irl) ETF Public Limi.. 2.35 % 0.00 %

-0.09 (-0.17%)

USD 0.33B
UBUW:F UBS (Irl) ETF Public Limi.. 2.35 % 0.00 %

-0.11 (-0.17%)

USD 0.02B
UBUS:XETRA UBS (Irl) ETF plc - Facto.. 2.35 % 0.00 %

-0.05 (-0.17%)

USD 0.49B
UBUW:XETRA UBS (Irl) ETF plc - Facto.. 2.35 % 0.00 %

-0.11 (-0.17%)

USD 0.05B
NSGE:CA NBI Sustainable Global Eq.. 2.32 % 0.00 %

N/A

CAD 0.53B
TDOC:CA TD Global Healthcare Lead.. 2.28 % 0.00 %

-0.01 (-0.17%)

CAD 0.07B
FHH:CA First Trust AlphaDEX US H.. 2.28 % 0.77 %

N/A

CAD 0.01B
FHH-F:CA First Trust AlphaDEX U.S... 2.28 % 0.00 %

N/A

CAD 0.01B
FXH First Trust Health Care A.. 2.15 % 0.63 %

-1.03 (-0.17%)

USD 1.33B
XHS SPDR® S&P Health Care Se.. 2.13 % 0.35 %

-0.97 (-0.17%)

USD 0.08B
FDWM Fidelity Covington Trust .. 1.84 % 0.00 %

-0.04 (-0.17%)

USD 3.69M
SPVM Invesco S&P 500 Value wit.. 1.79 % 0.39 %

+0.03 (+-0.17%)

USD 0.09B
RYH 1.72 % 0.40 %

N/A

N/A
HONR 1.20 % 0.65 %

N/A

N/A
VVL:CA Vanguard Global Value Fac.. 0.64 % 0.40 %

+0.16 (+-0.17%)

CAD 0.35B
SMD 0.45 % 0.10 %

N/A

N/A
ESGL ESGL Holdings Limited Ord.. 0.00 % 0.40 %

+0.01 (+-0.17%)

USD 5.46M
DUSA 0.00 % 0.63 %

N/A

N/A
DRFU:CA Desjardins RI USA Multifa.. 0.00 % 0.57 %

N/A

CAD 5.97M
RYF 0.00 % 0.40 %

N/A

N/A
XXM:CA 0.00 % 0.68 %

N/A

N/A
XMWD:LSE Xtrackers MSCI World Swap.. 0.00 % 0.00 %

-0.30 (-0.17%)

USD 4.03B
IMCG iShares Morningstar Mid-C.. 0.00 % 0.00 %

-0.31 (-0.17%)

N/A

Market Performance

  Market Performance vs. Industry/Classification (Other) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 8.16% 76% C+ 76% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.16% 77% C+ 75% C
Trailing 12 Months  
Capital Gain 25.11% 90% A- 88% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 25.11% 89% A- 86% B+
Trailing 5 Years  
Capital Gain 86.87% 85% B 92% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 86.87% 85% B 90% A-
Average Annual (5 Year Horizon)  
Capital Gain 14.71% 80% B- 79% B-
Dividend Return 14.71% 78% C+ 77% C+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 19.52% 73% C 72% C
Risk Adjusted Return 75.37% 98% N/A 97% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (HKD)

Quarterly Financials (HKD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike